Back to Search
DAVID DAIKH, M.D.,PH.D
M.D.,PH.D
Rheumatology Physician
NPI: 1740363654IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
MD192752(OR)
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
MD192752(OR)
CMS Specialties
PrimaryRHEUMATOLOGY
Education
OREGON HEALTH SCIENCES UNIVERSITY SCHOOL OF MEDICINE
Class of 1991
Research & Publications (16)
Treatment of autoimmunity by inhibition of T cell costimulation.
PMID 11505969·Adv Exp Med Biol·2001
6-review
Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide.
PMID 11207238·J Immunol·2001
4-observational
Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells.
PMID 19551149·PLoS One·2009
7-preclinical
B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiency.
PMID 19001138·J Exp Med·2008
7-preclinical
CTLA-4: a key regulatory point in the control of autoimmune disease.
PMID 18613834·Immunol Rev·2008
6-review
An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus.
PMID 18438845·Arthritis Rheum·2008
7-preclinical
Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?
PMID 17556720·Am J Respir Crit Care Med·2007
8-other
Novel model of antigen-specific induction of bile duct injury.
PMID 17087941·Gastroenterology·2006
7-preclinical
Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells.
PMID 16849451·J Immunol·2006
4-observational
Inhibition of T cell costimulation: an emerging therapeutic strategy for autoimmune rheumatic diseases.
PMID 16583382·Arthritis Rheum·2006
7-preclinical
Prevention of renal damage in murine lupus nephritis by CTLA-4Ig and cyclophosphamide.
PMID 15146424·Arthritis Rheum·2004
7-preclinical
Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis.
PMID 12209493·Arthritis Rheum·2002
5-case
Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis.
PMID 12077033·BMJ·2002
3-trial
An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity.
PMID 11163182·Cell·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3181 SW SAM JACKSON PARK RD
PORTLAND, OR 97239 - Phone
- (503) 494-8637
Quick Facts
- NPI
- 1740363654
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 35
- Publications
- 16
Are you this provider?
Claim Your Profile